Education
About Us
Working with TipRanks
Follow Us
AxoGen (AXGN)
NASDAQ:AXGN
Earnings Data
Report Date
Nov 11, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.07Last Year’s EPS
0.07Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected strong revenue growth and successful strategic execution, particularly in high potential accounts and surgeon training. Challenges remain with gross margin pressures and potential logistical changes due to the BLA approval process. However, the overall financial performance and raised guidance indicate a positive trajectory.Company Guidance
Strong Revenue Growth
Q2 sales increased to $56.7 million, growing 18.3% year-over-year. This reflects double-digit growth across all nerve repair target markets, including extremities, oral maxillofacial and head and neck, and breast.
High Potential Accounts Performance
Approximately 70% of revenue growth driven by high potential accounts. Average high potential account productivity is up 21% year-over-year.
Surgeon Training Success
Met or on track to meet 2025 training targets across all segments, including breast, extremities, and oral maxillofacial and head and neck.
Commercial Coverage Expansion
17 million additional lives covered year-to-date, bringing coverage amongst commercial payers to more than 55%.
Financial Performance and Outlook
Net income for the quarter was $0.6 million, compared to a net loss of $1.9 million in the second quarter of 2024. Adjusted EBITDA for the quarter was $9.3 million. Revenue guidance for 2025 raised to at least 17% growth.
AXGN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AXGN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2025 | $12.55 | $13.72 | +9.32% |
May 08, 2025 | $16.39 | $12.59 | -23.18% |
Feb 25, 2025 | $18.01 | $20.11 | +11.66% |
Nov 07, 2024 | $15.33 | $13.27 | -13.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AxoGen (AXGN) report earnings?
AxoGen (AXGN) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).
What is AxoGen (AXGN) earnings time?
AxoGen (AXGN) earnings time is at Nov 11, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AXGN EPS forecast?
AXGN EPS forecast for the fiscal quarter 2025 (Q3) is 0.07.